InnoCare Pharma (9969.HK) Earnings Analysis

InnoCare Pharma (9969.HK) next reports earnings on 2026-08-25. Trailing P/E 30.68.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 9969.HK next report earnings?

Next earnings date2026-08-25
Consensus EPS estimaten/a
Revenue estimate0.68B

9969.HK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-230.06819 HKDn/an/an/a
2026-03-250.445 HKDn/an/an/a
2025-11-13-0.02187 HKDn/an/an/a
2025-08-19-0.04337 HKDn/an/an/a
2024-12-31-0.10989 HKDn/an/an/a
2024-11-11-0.00794 HKDn/an/an/a
2024-08-20-0.08591 HKDn/an/an/a

9969.HK valuation and analyst view

Trailing P/E30.68
Trailing EPS0.40817 HKD
Price / book2.96
Dividend yield0.00%
Market cap21.63B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is InnoCare Pharma (9969.HK)'s next earnings date?

InnoCare Pharma is next scheduled to report on 2026-08-25 and revenue estimate of 0.68B.

Did 9969.HK beat earnings last quarter?

Consensus estimate data was not available for 9969.HK's 2026-04-23 report.

What is 9969.HK's current P/E ratio and EPS?

9969.HK trades at a trailing P/E of 30.68 on trailing EPS of 0.408169952746665 HKD.

What do analysts rate 9969.HK?

9969.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.